Experts at Huntsman Cancer Institute answer frequently asked questions about multiple myeloma, including how the disease works and what treatment options are available.
Each month, we’d like to highlight some current work at Huntsman Cancer Institute. See how a potential new immunotherapy for breast cancer is being developed, learn about research being done...
When Jeanette Nielsen was diagnosed with multiple myeloma, she turned to Cancer Institute. Past clinical trials helped with her treatment and now she wants to pay it forward.
New members added to The Society of Huntsman Translational Scholars. They include Gita Suneja, MD, MS; Siwen Hu-Lieskovan, MD, PhD; and Douglas Sborov, MD, MS.
Douglas Sborov, MD, discusses the multiple myeloma and clinical trials programs at Huntsman Cancer Institute, why this work is so meaningful, and how a Robin Williams character resonates with him.
Though multiple myeloma is a very treatable disease, we continue to press forward in search of a cure and new treatments to improve survival rates for this disease.
When Doug Stewart received an MRI after hurting his neck in a biking accident, the images revealed tumors wrapped around his spine. Doug was diagnosed with multiple myeloma. While recovering...
"No one is guaranteed tomorrow. But here I am still," says Dan Bammes, who was diagnosed with multiple myeloma in 2003. Dan says though the cancer-fighting drugs he took had...
Hematologist Tsewang Tashi, MD, shares what lead him to become a physician, what he is most proud of in his work at Huntsman Cancer Institute, and more.
Ruth Centurier-Harris and her family came to Salt Lake City from South Africa in 2015, expecting to be here for a short time. Two years later, Ruth received a devastating...
There are many challenges having a blood cancer with no cure. But we just try to enjoy the time we have. After his multiple myeloma diagnosis in 2015, Kenneth Henderson...
Clinical trials at Huntsman Cancer Institute (HCI) help find better ways to prevent, diagnose, and treat cancer by testing the safety and effectiveness of new drugs and treatments. On average...
